Effector Therapeutics Inc (EFTR) — Net Asset Momentum
Effector Therapeutics Inc (EFTR) recorded a net asset momentum of -248.7% as of December 2023, with net assets of $-5.79 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Effector Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Effector Therapeutics Inc Net Asset Momentum (2019–2023)
This chart tracks Effector Therapeutics Inc's year-over-year net asset growth across 5 annual reporting periods from 2019 to 2023. The most recent momentum reading is -248.7%, with net assets of $-5.79 Million USD as of December 2023. Read EFTR total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Effector Therapeutics Inc (2019–2023)
The table below shows the complete annual net asset history for Effector Therapeutics Inc from 2019 to 2023, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Effector Therapeutics Inc stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | $-5.79 Million | $20.54 Million | $26.34 Million | ▼ -248.7% |
| 2022 | $3.90 Million | $29.08 Million | $25.18 Million | ▼ -77.5% |
| 2021 | $17.28 Million | $54.06 Million | $36.77 Million | ▲ +113.1% |
| 2020 | $-132.25 Million | $16.70 Million | $148.95 Million | ▼ -855.6% |
| 2019 | $-13.84 Million | $5.09 Million | $18.93 Million | — |